The findings, which have not yet been published in a peer-reviewed journal, add to the growing evidence that GLP-1 agonists a class of medications that includes the popular diabetes and weight loss drugs Ozempic and Wegovy, from Novo Nordisk, and Mounjaro and Zepbound, from Eli Lilly may also protect the brain
Third-party tested purity GMP-compliant sourcing Available in various forms for research needs Transparent research-grade quality For research/educational purposes only
Yosipovitch G, DeVore A, Dawn A
Empty calories hit harder now Before GLP-1s, having chips, pastries, lattes, or fast food wasnt ideal, but it wasnt catastrophic
2025 Aug;173(2):360-366
Each session compounds on the last